MRNAModerna
$62.96+93% 1Y
$62.96
$22.3652 weeks$225.03
Latest close: a new 52-week highOct 9, 2026what changed →
Is the price fair?
What MRNA's price assumes
Moderna did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 11.4× revenue.
11.4
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.75
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 9.35
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.75
- EV / EBIToperating margin −149%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 9.35
- Market capitalisation
- $25.4B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry